全文获取类型
收费全文 | 3258篇 |
免费 | 153篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 54篇 |
妇产科学 | 119篇 |
基础医学 | 539篇 |
口腔科学 | 66篇 |
临床医学 | 233篇 |
内科学 | 725篇 |
皮肤病学 | 59篇 |
神经病学 | 484篇 |
特种医学 | 172篇 |
外科学 | 438篇 |
综合类 | 13篇 |
一般理论 | 2篇 |
预防医学 | 141篇 |
眼科学 | 31篇 |
药学 | 200篇 |
中国医学 | 2篇 |
肿瘤学 | 123篇 |
出版年
2023年 | 22篇 |
2022年 | 51篇 |
2021年 | 92篇 |
2020年 | 36篇 |
2019年 | 64篇 |
2018年 | 74篇 |
2017年 | 53篇 |
2016年 | 58篇 |
2015年 | 88篇 |
2014年 | 102篇 |
2013年 | 112篇 |
2012年 | 204篇 |
2011年 | 269篇 |
2010年 | 133篇 |
2009年 | 133篇 |
2008年 | 219篇 |
2007年 | 206篇 |
2006年 | 201篇 |
2005年 | 179篇 |
2004年 | 163篇 |
2003年 | 136篇 |
2002年 | 123篇 |
2001年 | 26篇 |
2000年 | 23篇 |
1999年 | 25篇 |
1998年 | 16篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1995年 | 15篇 |
1994年 | 10篇 |
1991年 | 11篇 |
1990年 | 14篇 |
1933年 | 17篇 |
1932年 | 20篇 |
1931年 | 14篇 |
1930年 | 16篇 |
1928年 | 15篇 |
1923年 | 12篇 |
1922年 | 13篇 |
1921年 | 9篇 |
1911年 | 9篇 |
1909年 | 11篇 |
1908年 | 17篇 |
1907年 | 17篇 |
1906年 | 14篇 |
1905年 | 12篇 |
1904年 | 9篇 |
1903年 | 9篇 |
1902年 | 13篇 |
1880年 | 11篇 |
排序方式: 共有3446条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
35.
36.
Paola Bianchi Elisa Fermo Kimberly Lezon-Geyda Eduard J. van Beers Holmes D. Morton Wilma Barcellini Bertil Glader Satheesh Chonat Yaddanapudi Ravindranath Peter E. Newburger Nina Kollmar Jenny M. Despotovic Madeleine Verhovsek Mukta Sharma Janet L. Kwiatkowski Kevin H. M. Kuo Marcin W. Wlodarski Hassan M. Yaish Susanne Holzhauer Heng Wang Joachim Kunz Kathryn Addonizio Hasan Al-Sayegh Wendy B. London Oliver Andres Richard van Wijk Patrick G. Gallagher Rachael F. F. Grace 《American journal of hematology》2020,95(5):472-482
Pyruvate kinase (PK) deficiency is a rare recessive congenital hemolytic anemia caused by mutations in the PKLR gene. This study reports the molecular features of 257 patients enrolled in the PKD Natural History Study. Of the 127 different pathogenic variants detected, 84 were missense and 43 non-missense, including 20 stop-gain, 11 affecting splicing, five large deletions, four in-frame indels, and three promoter variants. Within the 177 unrelated patients, 35 were homozygous and 142 compound heterozygous (77 for two missense, 48 for one missense and one non-missense, and 17 for two non-missense variants); the two most frequent mutations were p.R510Q in 23% and p.R486W in 9% of mutated alleles. Fifty-five (21%) patients were found to have at least one previously unreported variant with 45 newly described mutations. Patients with two non-missense mutations had lower hemoglobin levels, higher numbers of lifetime transfusions, and higher rates of complications including iron overload, extramedullary hematopoiesis, and pulmonary hypertension. Rare severe complications, including lower extremity ulcerations and hepatic failure, were seen more frequently in patients with non-missense mutations or with missense mutations characterized by severe protein instability. The PKLR genotype did not correlate with the frequency of complications in utero or in the newborn period. With ICCs ranging from 0.4 to 0.61, about the same degree of clinical similarity exists within siblings as it does between siblings, in terms of hemoglobin, total bilirubin, splenectomy status, and cholecystectomy status. Pregnancy outcomes were similar across genotypes in PK deficient women. This report confirms the wide genetic heterogeneity of PK deficiency. 相似文献
37.
Gemma Mayor-Subirana José Yagüe-García Eduard Valmaseda-Castellón Josep Arnabat-Domínguez Leonardo Berini-Aytés Cosme Gay-Escoda 《Medicina oral, patología oral y cirugía bucal》2014,19(2):e192-e201
Objectives: To evaluate the efficacy of Oraqix® during scaling and root planing (SRP) in comparison with 20% benzocaine and placebo.
Study Design: 15 patients requiring 4 sessions of SRP were enrolled. For each patient, Oraqix®, Hurricaine®, vaseline or no anesthetic product were randomly assigned each to a quadrant. Treatment pain was evaluated on a 100 mm Visual Analog Scale (VAS) and on a Verbal Rating Scale (VRS). The amount of product administered, the need to re-anesthetise, patient and operator satisfaction and the onset of side-effects were also recorded.
Results: Oraqix® was significantly better than nothing, with a reduction of VAS score to 13.3 units, but without significant differences with Vaseline or Hurricaine®. Oraqix® was better in VRS reduction than not using any anesthetic (p=0.001) or using vaseline (p=0.024), but similar to Hurricaine® (p=0.232).
Conclusions: Oraqix® effectively controls pain in SRP procedures, with few side-effects and a good acceptance on the part of patients and clinicians.
Key words:Controlled clinical trial, topical anesthetic, scaling and root planing. 相似文献
38.
39.
40.